An international, multicentre survey of  -lactam antibiotic therapeutic drug monitoring practice in intensive care units

Protein Binding of β-Lactam Antibiotics in Critically Ill Patients: Can We Successfully Predict Unbound Concentrations?

(2013) Gloria Wong et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetics of Meropenem in Critically Ill Patients With Severe Infections

(2013) Lutz Binder et al.   THERAPEUTIC DRUG MONITORING

Dosing Nomograms for Attaining Optimum Concentrations of Meropenem by Continuous Infusion in Critically Ill Patients with Severe Gram-Negative Infections: a Pharmacokinetics/Pharmacodynamics-Based Approach

(2012) Federico Pea et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Optimal Meropenem Concentrations To Treat Multidrug-Resistant Pseudomonas aeruginosa Septic Shock

(2012) Fabio Silvio Taccone et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Case-Control Study of Drug Monitoring of  -Lactams in Obese Critically Ill Patients

(2012) M. Hites et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetics of Ampicillin/Sulbactam in Critically Ill Patients with Acute Kidney Injury undergoing Extended Dialysis

(2012) J. M. Lorenzen et al.   Clinical Journal of the American Society of Nephrology

Quantification of seven β-lactam antibiotics and two β-lactamase inhibitors in human plasma using a validated UPLC-MS/MS method

(2012) Mieke Carlier et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

β-Lactam therapeutic drug monitoring in the critically ill: optimising drug exposure in patients with fluctuating renal function and hypoalbuminaemia

(2012) Yoshiro Hayashi et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Rapid quantification of six β-lactams to optimize dosage regimens in severely septic patients

(2012) Fleur Wolff et al.   TALANTA

Therapeutic Drug Monitoring of Beta-Lactam Antibiotics in Burns Patients—A One-Year Prospective Study

(2012) Bhavik M. Patel et al.   THERAPEUTIC DRUG MONITORING

TDM-Guided Therapy with Daptomycin and Meropenem in a Morbidly Obese, Critically Ill Patient

(2011) Federico Pea et al.   ANNALS OF PHARMACOTHERAPY

Population pharmacokinetics of ceftriaxone in critically ill septic patients: a reappraisal

(2011) Denis Garot et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Therapeutic drug monitoring of antimicrobials

(2011) Jason A. Roberts et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Ceftazidime dosage regimen in intensive care unit patients: from a population pharmacokinetic approach to clinical practice via Monte Carlo simulations

(2011) Bernard Georges et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Subtherapeutic Initial β-Lactam Concentrations in Select Critically Ill Patients

(2011) Andrew A. Udy et al.   CHEST

Survival in neutropenic patients with severe sepsis or septic shock*

(2011) Matthieu Legrand et al.   CRITICAL CARE MEDICINE

Appropriate Antibiotic Dosage Levels in the Treatment of Severe Sepsis and Septic Shock

(2011) Fabio Silvio Taccone et al.   Current Infectious Disease Reports

Meropenem Dosing in Critically Ill Patients with Sepsis Receiving High-Volume Continuous Venovenous Hemofiltration

(2010) I. Bilgrami et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

High Cefepime Plasma Concentrations and Neurological Toxicity in Febrile Neutropenic Patients with Mild Impairment of Renal Function

(2010) F. Lamoth et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience

(2010) E. Nagy et al.   CLINICAL MICROBIOLOGY AND INFECTION

Daily serum piperacillin monitoring is advisable in critically ill patients

(2010) Nicolas Blondiaux et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Therapeutic drug monitoring of β-lactams in critically ill patients: proof of concept

(2010) Jason A. Roberts et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Antibiotic use in 530 French hospitals: results from a surveillance network at hospital and ward levels in 2007

(2010) C. Dumartin et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: special emphasis on unbound pharmacokinetics

(2010) M. Ulldemolins et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Augmented Renal Clearance

(2009) Andrew A. Udy et al.   CLINICAL PHARMACOKINETICS

Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

(2008) M. Rybak et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections

(2008) Peggy S. McKinnon et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS